Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Hatz

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|October 7, 2021
Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and SwitzerlandAlbert J Augustin, Matthias D Becker, Katja Hatz, et al.
European Journal of Ophthalmology|October 15, 2016
Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic resultsKatja Hatz, Ulrike Schneider, Bernhard Henrich, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 29, 2008
Preservative-free triamcinolone acetonide suspension developed for intravitreal injectionChristoph Bitter, Katja Suter, Verena Figueiredo, et al.
Ophthalmic Research|March 23, 2018
Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome PredictorsMaria-Magdalena Guichard, Anton R Xavier, Cengiz Türksever, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 5, 2014
Ranibizumab plus verteporfin photodynamic therapy in neovascular age-related macular degeneration: 12 months of retreatment and vision outcomes from a randomized studyKatja Hatz, Ulrike Schneider, P Bernhard Henrich, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 29, 2026
Crucial Role of Spectral Domain OCT in the Diagnosis and Follow-up of Acute Syphilitic Posterior Placoid Chorioretinitis (ASPPC) - a Case SeriesAngelica Rizzato, Laura Hoffmann, Florian Weisskopf, et al.
BMC Ophthalmology|December 2, 2024
Aflibercept high-dose (8mg) related intraocular inflammation (IOI) - a case seriesLaura Hoffmann, Stephan Michels, Chiara Eandi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular DegenerationSouska Zandi, Florian Weisskopf, Justus G Garweg, et al.
Ophthalmic Research|January 26, 2021
Predictors for 2-Year Functional and Morphological Outcomes of a Treat-and-Extend Regimen with Ranibizumab in Patients with Diabetic Macular EdemaHelena Giannakaki-Zimmermann, Alexandra Behrndt, Laura Hoffmann, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 15, 2018
Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-and-Extend RegimenKatja Hatz, Frank Zimmermann, Dimitrios Kardamakis, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Clinical Ophthalmology (Auckland, N.Z.)|October 7, 2021
Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and SwitzerlandAlbert J Augustin, Matthias D Becker, Katja Hatz, et al.
European Journal of Ophthalmology|October 15, 2016
Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic resultsKatja Hatz, Ulrike Schneider, Bernhard Henrich, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 29, 2008
Preservative-free triamcinolone acetonide suspension developed for intravitreal injectionChristoph Bitter, Katja Suter, Verena Figueiredo, et al.
Ophthalmic Research|March 23, 2018
Spectral-Domain Optical Coherence Tomography-Driven Treat-and-Extend and Pro Re Nata Regimen in Patients with Macular Oedema due to Retinal Vein Occlusion: 24-Month Evaluation and Outcome PredictorsMaria-Magdalena Guichard, Anton R Xavier, Cengiz Türksever, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 5, 2014
Ranibizumab plus verteporfin photodynamic therapy in neovascular age-related macular degeneration: 12 months of retreatment and vision outcomes from a randomized studyKatja Hatz, Ulrike Schneider, P Bernhard Henrich, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 29, 2026
Crucial Role of Spectral Domain OCT in the Diagnosis and Follow-up of Acute Syphilitic Posterior Placoid Chorioretinitis (ASPPC) - a Case SeriesAngelica Rizzato, Laura Hoffmann, Florian Weisskopf, et al.
BMC Ophthalmology|December 2, 2024
Aflibercept high-dose (8mg) related intraocular inflammation (IOI) - a case seriesLaura Hoffmann, Stephan Michels, Chiara Eandi, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 19, 2017
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular DegenerationSouska Zandi, Florian Weisskopf, Justus G Garweg, et al.
Ophthalmic Research|January 26, 2021
Predictors for 2-Year Functional and Morphological Outcomes of a Treat-and-Extend Regimen with Ranibizumab in Patients with Diabetic Macular EdemaHelena Giannakaki-Zimmermann, Alexandra Behrndt, Laura Hoffmann, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|February 15, 2018
Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-and-Extend RegimenKatja Hatz, Frank Zimmermann, Dimitrios Kardamakis, et al.
Pageof 5